SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-250796
Filing Date
2024-11-04
Accepted
2024-11-04 19:49:25
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE PRIME FUND, L.P.LONGITUDE PRIME PARTNERS, LLCLONGITUDE VENTURE PARTNERS IV, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d811011dsc13da.htm SC 13D/A 113804
  Complete submission text file 0001193125-24-250796.txt   115616
Mailing Address 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 94025
Business Address 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners IV, LLC (Filed by) CIK: 0001829169 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Subject) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92556 | Film No.: 241425230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)